
DISCO Pharmaceuticals gets $40M upfront from AbbVie and could earn up to $2.5B in milestones to develop AND-gated bispecifics for solid tumors.
June 2004 Table of Contents
over 22 years ago
Why Alliances Failover 22 years ago
Hire Expectationsover 22 years ago
DTC's Next Chapter





